Exercise attenuates pulmonary injury in mice with bleomycin-induced pulmonary fibrosis

Experimental Biology and Medicine

Volumn 237, Issue 8, 2012, Pages 873-883

  Prata, Luana O ^a   Oliveira, Fabrício M S ^a   Ribeiro, Tatiana M S ^a   Almeida, Pedro W M ^a   Cardoso, Jefferson A ^a   Rodrigues Machado, Maria da Glória ^a   Caliari, Marcelo V ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Exercise training; Idiopathic pulmonary fibrosis; Interstitial lung diseases; Surfactant protein A; Type I collagen

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; FORMALDEHYDE; PARAFFIN; SODIUM CHLORIDE; SURFACTANT PROTEIN A;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; COMPARATIVE STUDY; CONNECTIVE TISSUE; CONTROLLED STUDY; DIGITAL MORPHOMETRY; ENDURANCE; EXERCISE; EXERCISE TOLERANCE; EXPERIMENTAL MOUSE; FIBROSING ALVEOLITIS; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG INJURY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; SEDENTARY LIFESTYLE; SWIMMING; SWIMMING POOL;

ANIMALS; BLEOMYCIN; COLLAGEN TYPE I; HISTOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INSTILLATION, DRUG; LUNG; LUNG INJURY; MALE; MICE; MICE, INBRED BALB C; PHYSICAL CONDITIONING, ANIMAL; PNEUMOCYTES; PULMONARY FIBROSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; TRACHEA;

EID: 84865313573     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2012.011334     Document Type: Article

References (32)

1. Kinnula VL. Redox imbalance and lung fibrosis. Antioxid Redox Signal 2008;10:303-19
2. Zompatori M, Bna C, Poletti V, Spaggiari E, Ormitti F, Calabro E, Tognini G, Sverzellati N. Diagnostic imaging of diffuse infiltrative disease of the lung. Respiration 2004;71:4-19
3. Gao F, Kinnula VL, Myllaeniemi M, Oury TD. Extracellular superoxide dismutase in pulmonary. Antioxid Redox Signal 2008;10:343-54
4. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008;40:362-82
5. Kuroki Y, Takahashi H, Chiba H, Akino T. Surfactant proteins A and D: disease markers. Biochim Biophys Acta 1998;1408:334-45
6. Elhalwagi BM, Zhang M, Ikegami M, Iwamoto HS, Morris RE, Miller ML, Dienger K, Mccormack FX. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol 1999;21:380-7
7. Kottmann RM, Hogan CM, Phipps RP, Sime PJ. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology 2009;14:917-33
8. Spruit MA, Janssen DJA, Franssen FME, Wouters EFM. Rehabilitation and palliative care in lung fibrosis. Respirology 2009;14:781-7
9. Lacerda AC, Rodrigues-Machado MdaG, Mendes PL, Novaes RD, Carvalho GM, Zin WA, Gripp F, Coimbra CC. Paraquat (PQ)-induced pulmonary fibrosis increases exercise metabolic cost, reducing aerobic performance in rats. J Toxicol Sci 2009;34:671-9
10. Almeida PWM, Gomes-Filho A, Ferreira AJ, Rodrigues CEM, Dias-Peixoto MF, Russo RC, Teixeira MM, Cassali GD, Ferreira E, Santos IC, Garcia AMC, Silami-Garcia E, Wisloff U, Pussieldi GA. Swim training suppresses tumor growth in mice. J Appl Physiol 2009;107:261-5
11. Matsumoto K, Ishihara K, Tanaka K, Inoue K, Fushiki T. An adjustable-current swimming pool for the evaluation of endurance capacity of mice. J Appl Physiol 1996;81:1843-9
12. Gobatto CA, Mello MAR, Sibuya CY, Azevedo JRM, Santos LA, Kokubun E. Maximal lactate steady state in rats submitted to swimming exercise. Comp Biochem Physiol 2001;130:21-7
13. Caliari MV, do Pilar Machado R, de Lana M, Caja RA, Carneiro CM, Bahia MT, dos Santos CA, Magalhães GA, Sampaio IB, Tafuri WL. Quantitative analysis of cardiac lesions in chronic canine chagasic cardiomyopathy. Rev Inst Med Trop Sao Paulo 2002;44:273-8
14. Jastrzêbski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol 2006;57:139-48
15. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294:152-60.
16. Chua F, Gauldie J, Geoffrey LJ. Pulmonary fibrosis searching for model answers. Am J Respir Cell Mol Biol 2005;33:9-13
17. Mura M, Ferretti A, Ferro O, Zompatori M, Cavalli A, Schiavina M, Fabbri M. Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis. Respiration 2006;73:495-502
18. Dolhnikoff M, Mauad T, Ludwig MS. Extracellular matrix and oscillatory mechanics of rat lung parenchyma in bleomycin-induced fibrosis. Am J Respir Crit Care Med 1999;160:1750-7
19. Russo RC, Guabiraba R, Garcia CC, Barcelos LS, Roffe E, Souza ALS, Amaral FA, Cisalpino D, Cassali GD, Doni A, Bertini R, Teixeira MM. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 2009;40:410-21
20. Hemnes AR, Zaiman A, Champion HC. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation. Am J Physiol Lung Cell Mol Physiol 2008;294:24-33
21. Manali ED, Moschos C, Triantafillidou C, Kotanidou A, Psallidas I, Karabela SP, Roussos C, Papiris S, Armaganidis A, Stathopoulos GT, Maniatis NA. Static and dynamic mechanics of the murine lung after intratracheal bleomycin. BMC Pulm Med 2011;11:1-13
22. Serrano-Mollar A, Nacher M, Gay-Jordi G, Closa D, Xaubet A Bulbena O. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2007;176:1261-8
23. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus. Classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304
24. International Consensus Statement. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000;161:646-64
25. Goldstein RH. Control of type I collagen formation in the lung. AmJ Physiol 1991;261:L29-40
26. Entzian P, Huckstadt A, Kreipe H, Barth J. Determination of serum concentrations of type III procollagen peptide in mechanically ventilated patients. Pronounced augmented concentrations in the adult respiratory distress syndrome. Am Rev Respir Dis 1990;142:1079-82
27. Vieira RP, Claudino RC, Duarte ACS, Santos ABG, Perini A, Neto HCCF, Mauad T, Martins MA, Dolhnikoff M, Carvalho CRF. Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice. Am J Respir Crit Care Med 2007;176:871-7
28. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005;98:1154-62
29. Hardie WD, Glasser SW, Hagood JS. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 2009;175:3-16
30. Wu Z, Yang L, Cai L, Zhang M, Cheng X, Yang X, Xu J. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res 2007;7:8-1
31. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-5
32. Takahashi H, Sano H, Chiba H, Kuroki Y. Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases. Curr Pharm Des 2006;12:589-98.